High-resolution Intra-operative PSMA PET-CT in Prostate Cancer

Description:

This is a Single-center, diagnostic open-label prospective, pilot study in a total of 10 patients affected by Prostate cancer (PCa) with a risk of lymph node invasion (LNI) higher than 5% and candidates for a robot-assisted radical prostatectomy (RARP) with an extended pelvic lymph node dissection (ePLND) . The aim of the trial is to evaluate the feasibility and accuracy and clinical value of a novel high-resolution perioperative PET-CT-scan for intraoperative margin and lymph node invasion assessment, after 18F-PSMA injection, using histopathology as the gold standard.

Sponsor:

IRCCS San Raffaele

Contacts:

GIORGIO GANDAGLIA (CONTACT)

gandaglia.giorgio@hsr.it

+39 02 26438068

LUCIA DAMBROSIO (CONTACT)

dambrosio.lucia@hsr.it

Inclusion
  • Patient is indicated to undergo radical prostatectomy and ePLND.
  • Patient is confirmed with high risk prostate cancer.
Exclusion
  • Patient has active viral or fungal infection.
  • Patient previously received radiotherapy of the prostate.